Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Roblox
RBLX
|
+$557M |
| 2 |
JPMorgan Chase
JPM
|
+$497M |
| 3 |
Amazon
AMZN
|
+$492M |
| 4 |
AT&T
T
|
+$448M |
| 5 |
Coinbase
COIN
|
+$338M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$893M |
| 2 |
Advanced Micro Devices
AMD
|
+$706M |
| 3 |
Qualcomm
QCOM
|
+$580M |
| 4 |
Adobe
ADBE
|
+$542M |
| 5 |
Johnson & Johnson
JNJ
|
+$455M |
Sector Composition
| 1 | Healthcare | 19.45% |
| 2 | Technology | 17.76% |
| 3 | Consumer Staples | 10.28% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Financials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Live Ventures
LIVE
$53.9M
| $1.6M | ﹤0.01% |
50,599
-500
| -1% | -$15.8K |
|
2327
Vistra
VST
$70.6B
| $1.6M | ﹤0.01% |
70,033
-647,500
| -90% | -$14.7M |
|
|
AINC
2328
DELISTED
Ashford Inc.
AINC
| $1.59M | ﹤0.01% |
95,653
+9,900
| +12% | +$165K |
|
2329
Bio-Rad Laboratories Class B
BIO.B
| $1.59M | ﹤0.01% |
2,200
-100
| -4% | -$72.3K |
|
|
NNDM
2330
Nano Dimension
NNDM
$322M
| $1.59M | ﹤0.01% |
+418,527
| New | +$1.59M |
|
2331
First Bank
FRBA
$406M
| $1.59M | ﹤0.01% |
109,369
-387
| -0.4% | -$5.62K |
|
2332
Great Elm Group
GEG
$82.6M
| $1.59M | ﹤0.01% |
758,876
-25,688
| -3% | -$53.7K |
|
2333
First Trust Enhanced Short Maturity ETF
FTSM
$6.17B
| $1.59M | ﹤0.01% |
26,500
+8,293
| +46% | +$496K |
|
2334
Fidelity MSCI Information Technology Index ETF
FTEC
$15.6B
| $1.58M | ﹤0.01% |
11,700
+1,900
| +19% | +$257K |
|
2335
Prelude Therapeutics
PRLD
$58.9M
| $1.58M | ﹤0.01% |
+127,200
| New | +$1.58M |
|
|
TREC
2336
DELISTED
Trecora Resources
TREC
| $1.58M | ﹤0.01% |
195,985
-55,800
| -22% | -$451K |
|
2337
Outlook Therapeutics
OTLK
$45.3M
| $1.58M | ﹤0.01% |
58,215
+45,476
| +357% | +$1.24M |
|
2338
Winnebago Industries
WGO
$925M
| $1.58M | ﹤0.01% |
+21,100
| New | +$1.58M |
|
|
ZVO
2339
DELISTED
Zovio Inc. Common Stock
ZVO
| $1.58M | ﹤0.01% |
1,243,306
-39,400
| -3% | -$50K |
|
|
BNR
2340
Burning Rock Biotech
BNR
$89M
| $1.58M | ﹤0.01% |
16,539
+15,529
| +1,538% | +$1.48M |
|
|
UBX
2341
DELISTED
Unity Biotechnology
UBX
| $1.57M | ﹤0.01% |
107,770
+43,700
| +68% | +$638K |
|
|
EBIX
2342
DELISTED
Ebix Inc
EBIX
| $1.57M | ﹤0.01% |
51,580
+7,500
| +17% | +$228K |
|
|
PLYA
2343
DELISTED
Playa Hotels & Resorts
PLYA
| $1.56M | ﹤0.01% |
+196,000
| New | +$1.56M |
|
2344
Assembly Biosciences
ASMB
$158M
| $1.56M | ﹤0.01% |
55,919
+45,036
| +414% | +$1.26M |
|
|
NXGN
2345
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.56M | ﹤0.01% |
87,776
+13,800
| +19% | +$246K |
|
|
AATC
2346
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $1.56M | ﹤0.01% |
247,849
-300
| -0.1% | -$1.89K |
|
2347
Universal Electronics
UEIC
$59.6M
| $1.56M | ﹤0.01% |
38,200
-2,000
| -5% | -$81.5K |
|
2348
Vera Bradley
VRA
$57.3M
| $1.56M | ﹤0.01% |
182,900
-78,800
| -30% | -$670K |
|
2349
Brighthouse Financial
BHF
$2.63B
| $1.55M | ﹤0.01% |
30,000
-215,100
| -88% | -$11.1M |
|
2350
Cartesian Therapeutics
RNAC
$238M
| $1.55M | ﹤0.01% |
15,873
+7,133
| +82% | +$697K |
|